Dutch food-tech scale-up Revyve has raised nearly €24 million in a Series B funding round, bringing its total capital raised to over €40 million. The investment will accelerate the company’s commercial rollout of functional yeast proteins, designed to replace eggs and additives in mainstream food categories.
Series B Led by Institutional and Strategic Investors
The Series B round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL, with regional support from Brabantse Ontwikkelings Maatschappij (BOM) and strategic investments from Lallemand Bio-Ingredients’ Swiss affiliate Danstar Ferment and Grey Silo Ventures (CVC of Cereal Docks Group). Existing investors Oost NL and Royal Cosun also increased their commitment.
This diverse investor base combines institutional, public, and strategic expertise to support Revyve’s mission of reshaping the alternative protein space with next-generation, clean-label solutions.
Clean-Label Solutions for a Changing Food Landscape
Revyve produces highly functional yeast proteins that mimic the performance of eggs in bakery, sauces, alternative meat, and plant-based dairy products. Unlike many substitutes, Revyve’s ingredients are natural, sustainable, and price-competitive, helping manufacturers address three pressing industry challenges:
-
Rising egg costs – providing affordable and price-stable alternatives.
-
Scrutiny of ultra-processed foods – enabling additive-free, functional ingredients.
-
Sustainability pressures – helping brands reduce CO₂ footprints across the supply chain.
Cedric Verstraeten, CEO of Revyve, said:
“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction. This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide.”
Scaling Production in the Netherlands
In 2024, Revyve commissioned its first-of-a-kind (FOAK) production facility in Dinteloord, Netherlands. Already running at capacity for several customers, the facility demonstrates the company’s ability to produce industrial volumes. With the new investment, Revyve plans to expand output to over 1,600 tons per year, ensuring reliable supply for global accounts.
Verstraeten adds:
“Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time. With a stellar team and strong investor backing, we have an incredibly solid foundation for global expansion.”
Strong Investor Confidence
The Series B round underscores confidence in Revyve’s proprietary technology and market potential.
Hanna Zwietering, ABN AMRO SIF Senior Investment Manager, said:
“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey.”
Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL, added:
“With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”
Ingrid Nieweg, Investment Manager at BOM, commented:
“Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world.”
Strategic investors Lallemand Bio-Ingredients and Grey Silo Ventures bring deep expertise in yeast innovation and agri-food solutions, further strengthening Revyve’s growth trajectory.
Global Expansion and Market Outlook
With industrial production already serving customers across Europe, UK, USA, Canada, Mexico, and Australia, Revyve is poised for rapid global expansion. The company will showcase its latest applications and partnerships at major industry tradeshows this autumn, including Anuga.
Revyve’s functional yeast proteins provide a sustainable, clean-label alternative to eggs, positioning the company at the forefront of the next-generation alternative protein market.